Stereotactic Ablative Radiotherapy (SABR) is increasingly used to treat metastatic oligorecurrence and locoregional recurrences but limited evidence/guidance exists in the setting of pelvic re-irradiation. An international Delphi study was performed to develop statements to guide practice regarding patient selection, pre-treatment investigations, treatment planning, delivery and cumulative organs at risk (OARs) constraints. Forty-one radiation oncologists were invited to participate in three online surveys. In Round 1, information and opinion was sought regarding participants' practice. Guidance statements were developed using this information and in Round 2 participants were asked to indicate their level of agreement with each statement. C...
Aims: The non-surgical management of locally recurrent rectal cancer (LRRC) is an area of unmet ne...
Background: Oligometastases refer to a state of disease where cancer has spread bey...
Stereotactic ablative radiotherapy (SABR) is a form of very precise radiotherapy that delivers high ...
INTRODUCTION Stereotactic Ablative Radiotherapy (SABR) is increasingly used to treat metastatic o...
Stereotactic Ablative Radiotherapy (SABR) is increasingly used to treat metastatic oligorecurrence a...
Background and Purpose To perform a systematic review regarding the use of stereotactic ablative rad...
Background and purpose: To perform a systematic review regarding the use of stereotactic ablative ra...
Abstract Background Stereotactic Ablative Radiotherapy (SABR) is an effective treatment that improv...
Introduction Multiple considerations exist concerning Stereotactic Ablative Radiotherapy (SABR) i...
Item does not contain fulltextBACKGROUND AND PURPOSE: Between 30% and 47% of patients treated with d...
Up to 40% of patients who have received radiation for a pelvic malignancy will develop locoregional ...
Aim: Oligometastatic cancer is being increasingly managed with aggressive local therapy using stereo...
Background: Stereotactic ablative radiotherapy (SABR) has emerged as a new treatment option for pati...
Aims Stereotactic body radiotherapy (SBRT) for oligometastases is increasingly used with few evidenc...
BACKGROUND AND PURPOSE Between 30% and 47% of patients treated with definitive radiotherapy (RT) ...
Aims: The non-surgical management of locally recurrent rectal cancer (LRRC) is an area of unmet ne...
Background: Oligometastases refer to a state of disease where cancer has spread bey...
Stereotactic ablative radiotherapy (SABR) is a form of very precise radiotherapy that delivers high ...
INTRODUCTION Stereotactic Ablative Radiotherapy (SABR) is increasingly used to treat metastatic o...
Stereotactic Ablative Radiotherapy (SABR) is increasingly used to treat metastatic oligorecurrence a...
Background and Purpose To perform a systematic review regarding the use of stereotactic ablative rad...
Background and purpose: To perform a systematic review regarding the use of stereotactic ablative ra...
Abstract Background Stereotactic Ablative Radiotherapy (SABR) is an effective treatment that improv...
Introduction Multiple considerations exist concerning Stereotactic Ablative Radiotherapy (SABR) i...
Item does not contain fulltextBACKGROUND AND PURPOSE: Between 30% and 47% of patients treated with d...
Up to 40% of patients who have received radiation for a pelvic malignancy will develop locoregional ...
Aim: Oligometastatic cancer is being increasingly managed with aggressive local therapy using stereo...
Background: Stereotactic ablative radiotherapy (SABR) has emerged as a new treatment option for pati...
Aims Stereotactic body radiotherapy (SBRT) for oligometastases is increasingly used with few evidenc...
BACKGROUND AND PURPOSE Between 30% and 47% of patients treated with definitive radiotherapy (RT) ...
Aims: The non-surgical management of locally recurrent rectal cancer (LRRC) is an area of unmet ne...
Background: Oligometastases refer to a state of disease where cancer has spread bey...
Stereotactic ablative radiotherapy (SABR) is a form of very precise radiotherapy that delivers high ...